Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/139172
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | A randomised controlled trial of vaporised Δ⁹-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects |
Other Titles: | A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects |
Author: | Solowij, N. Broyd, S. Greenwood, L.M. van Hell, H. Martelozzo, D. Rueb, K. Todd, J. Liu, Z. Galettis, P. Martin, J. Murray, R. Jones, A. Michie, P.T. Croft, R. |
Citation: | European Archives of Psychiatry and Clinical Neuroscience: official organ of the German society for biological psychiatry, 2019; 269(1):17-35 |
Publisher: | Springer Science and Business Media LLC |
Issue Date: | 2019 |
ISSN: | 0940-1334 1433-8491 |
Statement of Responsibility: | Nadia Solowij, Samantha Broyd, Lisa, marie Greenwood, Hendrika van Hell, Dave Martelozzo, Kuna Rueb, Juanita Todd, Zheng Liu, Peter Galettis, Jennifer Martin, Robin Murray, Alison Jones, Patricia T. Michie, Rodney Croft |
Abstract: | Access to cannabis and cannabinoid products is increasing worldwide for recreational and medicinal use. Two primary compounds within cannabis plant matter, Δ⁹-tetrahydrocannabinol (THC) and cannabidiol (CBD), are both psychoactive, but only THC is considered intoxicating. There is significant interest in potential therapeutic properties of these cannabinoids and of CBD in particular. Some research has suggested that CBD may ameliorate adverse effects of THC, but this may be dose dependent as other evidence suggests possible potentiating effects of THC by low doses of CBD. We conducted a randomised placebo controlled trial to examine the acute effects of these compounds alone and in combination when administered by vaporisation to frequent and infrequent cannabis users. Participants (n = 36; 31 male) completed 5 drug conditions spaced one week apart, with the following planned contrasts: placebo vs CBD alone (400 mg); THC alone (8 mg) vs THC combined with low (4 mg) or high (400 mg) doses of CBD. Objective (blind observer ratings) and subjective (self-rated) measures of intoxication were the primary outcomes, with additional indices of intoxication examined. CBD showed some intoxicating properties relative to placebo. Low doses of CBD when combined with THC enhanced, while high doses of CBD reduced the intoxicating effects of THC. The enhancement of intoxication by low-dose CBD was particularly prominent in infrequent cannabis users and was consistent across objective and subjective measures. Most effects were significant at p < .0001. These findings are important to consider in terms of recommended proportions of THC and CBD in cannabis plant matter whether used medicinally or recreationally and have implications for novice or less experienced cannabis users. |
Keywords: | Δ9 -Tetrahydrocannabinol (THC); Cannabidiol (CBD); Cannabis; Cannabinoids; Intoxication; Synergistic effects |
Rights: | © Springer-Verlag GmbH Germany, part of Springer Nature 2019. |
DOI: | 10.1007/s00406-019-00978-2 |
Grant ID: | http://purl.org/au-research/grants/arc/FT110100752 http://purl.org/au-research/grants/nhmrc/1007593 |
Published version: | http://dx.doi.org/10.1007/s00406-019-00978-2 |
Appears in Collections: | Psychiatry publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.